HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peer Tfelt-Hansen Selected Research

Tryptamines (Triptans)

12/2021Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review.
2/2021Pharmacological strategies to treat attacks of episodic migraine in adults.
1/2021Onset of action in placebo-controlled migraine attacks trials: A literature review and recommendation.
5/2016The Evidence for Prescription Information for Possible Use of a Repeated Dose of Oral Triptans: A Comment.
1/2015Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists.
1/2013Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.
12/2012Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
5/2012Taking the negative view of current migraine treatments: the unmet needs.
2/2012Clinical pharmacology of current and future drugs for the acute treatment of migraine: a review and an update.
6/2011Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peer Tfelt-Hansen Research Topics

Disease

51Migraine Disorders (Migraine)
01/2022 - 03/2002
19Headache (Headaches)
10/2020 - 05/2005
7Pain (Aches)
10/2020 - 08/2008
6Cluster Headache (Cluster Headaches)
08/2015 - 04/2007
2Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 01/2009
1Secondary Headache Disorders
02/2021
1Pneumonia (Pneumonitis)
01/2016
1Juvenile Myoclonic Epilepsy
05/2013
1Seizures (Absence Seizure)
05/2013
1Epilepsy (Aura)
01/2013
1Migraine with Aura (Familial Hemiplegic Migraine)
01/2013
1Rhabdomyolysis
01/2009
1Tension-Type Headache (Tension Headache)
04/2007
1Prescription Drug Overuse
01/2007
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2004
1Intracranial Vasospasm
12/2004
1Peripheral Arterial Disease
12/2004

Drug/Important Bio-Agent (IBA)

19Tryptamines (Triptans)IBA
12/2021 - 03/2002
16Pharmaceutical PreparationsIBA
02/2021 - 10/2007
14Sumatriptan (Imigran)FDA LinkGeneric
12/2021 - 12/2006
8Pain-FreeIBA
04/2015 - 05/2005
6telcagepantIBA
06/2011 - 03/2009
4Calcitonin Gene-Related PeptideIBA
01/2020 - 06/2009
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2015 - 04/2008
3naratriptanFDA LinkGeneric
12/2021 - 10/2007
3erenumabIBA
10/2021 - 01/2020
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2021 - 04/2007
3zolmitriptan (Zomig)FDA Link
01/2021 - 06/2011
3galcanezumabIBA
01/2020 - 01/2015
3Propranolol (Inderal)FDA LinkGeneric
05/2012 - 08/2004
2lasmiditanIBA
01/2022 - 12/2012
2Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
02/2021 - 04/2011
2Monoclonal AntibodiesIBA
01/2020 - 01/2020
2Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2020 - 01/2011
2Dihydroergotamine (Agit)FDA LinkGeneric
10/2016 - 02/2014
2Verapamil (Calan)FDA LinkGeneric
08/2015 - 01/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 08/2008
2frovatriptan (Allegro)FDA Link
05/2012 - 06/2011
2Topiramate (Topamax)FDA LinkGeneric
05/2012 - 08/2004
2almotriptan (Axert)FDA Link
06/2011 - 06/2008
2Vasodilator Agents (Vasodilators)IBA
04/2011 - 03/2009
2olcegepantIBA
04/2011 - 06/2009
2Oxygen (Dioxygen)IBA
04/2010 - 04/2007
1ubrogepantIBA
01/2022
1eptinezumabIBA
01/2020
1fremanezumabIBA
01/2020
1Metoclopramide (Reglan)FDA LinkGeneric
03/2015
1Guanfacine (Tenex)FDA LinkGeneric
04/2014
1Lamotrigine (Lamictal)FDA LinkGeneric
05/2013
1Nitric Oxide Synthase (NO Synthase)IBA
01/2013
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2013
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2013
14- fluoro- N- (3- (1- methyl- 4- piperidinyl)- 1H- indol- 5- yl)benzamideIBA
12/2012
15-HT1F Serotonin ReceptorIBA
12/2012
1Serotonin (5 Hydroxytryptamine)IBA
12/2012
1Valproic Acid (Depakote)FDA LinkGeneric
05/2012
1rizatriptan (Maxalt)FDA Link
05/2012
1Type A Botulinum Toxins (Botox)FDA Link
11/2010
1Nitroglycerin (Dynamite)FDA LinkGeneric
04/2010
1NeuropeptidesIBA
06/2009
1Phenobarbital (Luminal)FDA Link
03/2009
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2009
1Cocaine (Cocaine HCl)IBA
01/2009
1isosorbide-5-mononitrate (Ismo)FDA LinkGeneric
08/2008
1NitratesIBA
08/2008
1Indomethacin (Indometacin)FDA LinkGeneric
06/2008
1Prochlorperazine (Compazine)FDA LinkGeneric
06/2008
1SodiumIBA
06/2008
1Caffeine (No Doz)FDA LinkGeneric
06/2008
1sumatriptan-naproxenFDA Link
06/2008
1eletriptan (Relpax)FDA Link
02/2008
1Ergot AlkaloidsIBA
04/2007
1Ibuprofen (Motrin)FDA LinkGeneric
02/2006
1rofecoxib (Vioxx)FDA Link
02/2006
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
12/2004
1Cilostazol (Pletal)FDA LinkGeneric
12/2004
1Phosphodiesterase 3 InhibitorsIBA
12/2004

Therapy/Procedure

7Therapeutics
02/2021 - 04/2007
1Oral Administration
01/2021
1Aftercare (After-Treatment)
01/2020
1Precision Medicine
05/2017
1Artificial Respiration (Mechanical Ventilation)
01/2016
1Drug Therapy (Chemotherapy)
04/2007
1Contraindications
01/2007